Pharmaceutical companies rely on layered systems that include raw material qualification, in-process testing, validated manufacturing controls, and independent quality audits at every stage of production, all governed by frameworks like current Good Manufacturing Practice (cGMP). Following a wave of high-profile API contamination recalls, these quality systems have moved from a back-office compliance function into a